Sacral neuromodulation in pediatric bladder and bowel dysfunctions: Literature review

Abstract

BACKGROUND: Sacral neuromodulation is a neurosurgical method for the correction of bladder and bowel dysfunctions of various origins that are refractory to conservative treatment.

AIM: To analyze chronic sacral neurostimulation results as a correction method for pediatric bladder and bowel dysfunction of various origins.

MATERIALS AND METHODS: The results of chronic sacral neurostimulation for treating urination and defecation disorders of various origins in children reported in the world literature were analyzed. The literature search was performed in the open electronic scientific databases eLIBRARY, PubMed, and Cochrane Library. The source selection was limited by 2002–2022.

RESULTS: Most authors report good and satisfactory results in the treatment of bladder and bowel dysfunction by sacral neurostimulation. However, the level of evidence on the effectiveness of sacral neurostimulation remains low because data were obtained from small and heterogeneous groups of patients and studies employed different criteria for inclusion and methods for analyzing the results.

CONCLUSIONS: Conducting randomized trials will allow for the assessment of the efficacy and safety of sacral neuromodulation in children with bladder and bowel dysfunctions of various origins that are refractory to standard conservative treatment.

Keywords

sacral neuromodulation / bladder dysfunction / bowel disfunction / neurogenic bladder / neurogenic bowel disfunction / children

References

[1] Vaz GT, Vasconcelos MM, Oliveira EA, et al. Prevalence of lower urinary tract symptoms in school-age children. Pediatric Nephrology. 2012;27(4):597–603. DOI: 10.1007/s00467-011-2028-1

[2] Vaz G.T., Vasconcelos M.M., Oliveira E.A., et al. Prevalence of lower urinary tract symptoms in school-age children // Pediatric Nephrology. 2012. Vol. 27. No. 4. P. 597–603. DOI: 10.1007/s00467-011-2028-1

[3] Sampaio C, Sousa AS, Fraga LG, et al. Constipation and lower urinary tract dysfunction in children and adolescents: a population-based study. Front Pediatr. 2016;4:101. DOI: 10.3389/fped.2016.00101

[4] Sampaio C., Sousa A.S., Fraga L.G., et al. Constipation and lower urinary tract dysfunction in children and adolescents: a population-based study // Front. Pediatr. 2016. Vol. 4. P. 101. DOI: 10.3389/fped.2016.00101

[5] Sumboonnanond A, Sawangsuk P, Sungkabuth P, et al. Screening and management of bladder and bowel dysfunction in general pediatric outpatient clinic: a prospective observational study. BMC Pediatr. 2022;22:288. DOI: 10.1186/s12887-022-03360-9

[6] Sumboonnanond A., Sawangsuk P., Sungkabuth P., et al. Screening and management of bladder and bowel dysfunction in general pediatric outpatient clinic: a prospective observational study // BMC Pediatr. 2022. Vol. 22. P. 288. DOI: 10.1186/s12887-022-03360-9

[7] Yüksel S, Yurdakul AÇ, Zencir M, et al. Evaluation of lower urinary tract dysfunction in Turkish primary schoolchildren: an epidemiological study. J Pediatr Urol. 2014;10(6):1181–1186. DOI: 10.1016/j.jpurol.2014.05.008

[8] Yüksel S., Yurdakul A.Ç., Zencir M., et al. Evaluation of lower urinary tract dysfunction in Turkish primary schoolchildren: an epidemiological study // J. Pediatr. Urol. 2014. Vol. 10. No. 6. P. 1181–1186. DOI: 10.1016/j.jpurol.2014.05.008

[9] Austin PF, Bauer SB, Bower W, et al. The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the International Children’s Continence Society. Neurourol Urodyn. 2016;35(4):471–481. DOI: 10.1002/nau.22751

[10] Austin P.F., Bauer S.B., Bower W., et al. The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the International Children’s Continence Society // Neurourol. Urodyn. 2016. Vol. 35. No. 4. P. 471–481. DOI: 10.1002/nau.22751

[11] Lai HH, Shen B, Rawal A, et al. The relationship between depression and overactive bladder/urinary incontinence symptoms in the clinical OAB population. BMC Urol. 2016;16:60. DOI: 10.1186/s12894-016-0179-x

[12] Lai H.H., Shen B., Rawal A., et al. The relationship between depression and overactive bladder/urinary incontinence symptoms in the clinical OAB population // BMC Urol. 2016. Vol. 16. P. 60. DOI: 10.1186/s12894-016-0179-x

[13] Collis D, Kennedy-Behr A, Kearney L. The impact of bowel and bladder problems on children’s quality of life and their parents: a scoping review. Child Care Health Dev. 2019;45(1):1–14. DOI: 10.1111/cch.12620

[14] Collis D., Kennedy-Behr A., Kearney L. The impact of bowel and bladder problems on children’s quality of life and their parents: a scoping review // Child Care Health Dev. 2019. Vol. 45. No. 1. P. 1–14. DOI: 10.1111/cch.12620

[15] Santos JD, Lopes RI, Koyle MA. Bladder and bowel dysfunction in children: an update on the diagnosis and treatment of a common, but underdiagnosed pediatric problem. Can Urol Assoc J. 2017;11:S64–S72. DOI: 10.5489/cuaj.4411

[16] Santos J.D., Lopes R.I., Koyle M.A. Bladder and bowel dysfunction in children: An update on the diagnosis and treatment of a common, but underdiagnosed pediatric problem // Can. Urol. Assoc. J. 2017. Vol. 11. P. S64–S72. DOI: 10.5489/cuaj.4411

[17] Caldwell KPS. The electrical control of sphincter incompetence. Lancet. 1963;282:174–175. DOI: 10.1016/s0140-6736(63)92807-1

[18] Caldwell K.P.S. The electrical control of sphincter incompetence // Lancet. 1963. Vol. 282. P. 174–175. DOI: 10.1016/s0140-6736(63)92807-1

[19] Abello A, Das AK. Electrical neuromodulation in the management of lower urinary tract dysfunction: evidence, experience and future prospects. Ther Adv Urol. 2018;10(5):165–173. DOI: 10.1177/ 1756287218756082

[20] Abello A., Das A.K. Electrical neuromodulation in the management of lower urinary tract dysfunction: evidence, experience and future prospects // Ther. Adv. Urol. 2018. Vol. 10. No. 5. P. 165–173. DOI: 10.1177/ 1756287218756082

[21] Szymański JK, Słabuszewska-Jóźwiak A, Zaręba K, et al. Neuromodulation — a therapeutic option for refractory overactive bladder: a recent literature review. Videosurgery and Other Miniinvasive Techniques. 2019;14(4):476–485. DOI: 10.5114/wiitm.2019.85352

[22] Szymański J.K., Słabuszewska-Jóźwiak A., Zaręba K., et al. Neuromodulation — a therapeutic option for refractory overactive bladder: a recent literature review // Videosurgery and Other Miniinvasive Techniques. 2019. Vol. 14. No. 4. P. 476–485. DOI: 10.5114/wiitm.2019.85352

[23] Mass-Lindenbaum M, Calderón-Pollak D, Goldman HB, et al. Sacral neuromodulation — when and for who. Int Braz J Urol. 2021;47(3):647–656. DOI: 10.1590/S1677-5538.IBJU.2021.99.08

[24] Mass-Lindenbaum M., Calderón-Pollak D., Goldman H.B., et al. Sacral neuromodulation — when and for who // Int. Braz. J. Urol. 2021. Vol. 47. No. 3. P. 647–656. DOI: 10.1590/S1677-5538.IBJU.2021.99.08

[25] Tanagho EA, Schmidt RA. Bladder pacemaker: scientific basis and clinical future. Urology. 1982;20(6):614–619. DOI: 10.1016/0090-4295(82)90312-0

[26] Tanagho E.A., Schmidt R.A. Bladder pacemaker: scientific basis and clinical future // Urology. 1982. Vol. 20. No. 6. P. 61461–61469. DOI: 10.1016/0090-4295(82)90312-0

[27] Vaganee D, Fransen E, Voorham J, et al. Behind the scenes: an electromyographic interpretation of the pelvic floor contractions seen by the naked eye upon lead stimulation in sacral neuromodulation patients [Abstract]. Neurourol Urodyn. 2019;38:S446–S448.

[28] Vaganee D., Fransen E., Voorham J., et al. Behind the scenes: an electromyographic interpretation of the pelvic floor contractions seen by the naked eye upon lead stimulation in sacral neuromodulation patients [Abstract] // Neurourol. Urodyn. 2019. Vol. 38. Suppl. 3. P. S446–S448.

[29] Gill BC, Pizarro-Berdichevsky J, Bhattacharyya PK, et at. Real-time changes in brain activity during sacral neuromodulation for overactive bladder. J Urol. 2017;198:1379–1385. DOI: 10.1016/j.juro.2017.06.074

[30] Gill B.C., Pizarro-Berdichevsky J., Bhattacharyya P.K., et at. Real-time changes in brain activity during sacral neuromodulation for overactive bladder // J. Urol. 2017. Vol. 198. P. 1379–1385. DOI: 10.1016/j.juro.2017.06.074

[31] De Wachter S, Vaganee D, Kessler TM. Sacral neuromodulation: mechanism of action. Eur Urol Focus. 2020;6(5):823–825. DOI: 10.1016/j.euf.2019.11.018

[32] De Wachter S., Vaganee D., Kessler T.M. Sacral neuromodulation: mechanism of action // Eur. Urol. Focus. 2020. Vol. 6. No. 5. P. 823–825. DOI: 10.1016/j.euf.2019.11.018

[33] Strine AC, Keenan AC, King S, et al. Sacral neuromodulation in children. Current Bladder Dysfunction Reports. 2015;10(4):332–337. DOI: 10.1007/s11884-015-0322-7

[34] Strine A.C., Keenan A.C., King S., et al. Sacral neuromodulation in children // Current Bladder Dysfunction Reports. 2015. Vol. 10. No. 4. P. 332–337. DOI: 10.1007/s11884-015-0322-7

[35] Goldman HB., Lloyd JC, Noblett KL, et al. International continence society best practice statement for use of sacral neuromodulation. Neurourol Urodyn. 2018;37(5):1823–1848. DOI: 10.1002/nau.23515

[36] Goldman H.B., Lloyd J.C., Noblett K.L., et al. International continence society best practice statement for use of sacral neuromodulation // Neurourol. Urodyn. 2018. Vol. 37. No. 5. P. 1823–1848. DOI: 10.1002/nau.23515

[37] Beloy C, García-Novoa MA, Argibay S, et al. Update on sacral neuromodulation and overactive bladder in pediatrics: a systematic review. Archivos Espanoles de Urologia. 2021;74(7):699–708. DOI: 10.37554/en-20210307-3421-5

[38] Beloy C., García-Novoa M.A., Argibay S., et al. Update on sacral neuromodulation and overactive bladder in pediatrics: a systematic review // Archivos Espanoles de Urologia. 2021. Vol. 74. No. 7. P. 699–708. DOI: 10.37554/en-20210307-3421-5

[39] Dekopov AV, Tomskiy AA, Isagulyan ED, et al. Chronic sacral neuromodulation for pelvic floor dysfunction in children with spina bifida. Burdenko’s Journal of Neurosurgery. 2022;86(1):48–55. (In Russ.). DOI: 10.17116/neiro20228601148

[40] Декопов А.В., Томский А.А., Исагулян Э.Д., и др. Лечение нарушения функции тазовых органов у детей с миелодисплазией методом хронической сакральной нейростимуляции // Вопросы нейрохирургии имени Н.Н. Бурденко. 2022. T. 86. № 1. С. 48–55.

[41] Hoebeke P, Van Laecke E, Everaert K, et al. Transcutaneous neuromodulation for the urge syndrome in children: a pilot study. J Urol. 2001;166(6):2416–2419. DOI: 10.1016/S0022-5347(05)65605-4

[42] Hoebeke P., van Laecke E., Everaert K., et al. Transcutaneous neuromodulation for the urge syndrome in children: a pilot study // J. Urol. 2001. Vol. 166. No. 6. P. 2416–2419. DOI: 10.1016/S0022-5347(05)65605-4

[43] Butrick CW. Patient selection for sacral nerve stimulation. Int Urogynecol J. 2010:S447-S451. DOI: 10.1007/s00192-010-1274-2

[44] Butrick C.W. Patient selection for sacral nerve stimulation // Int. Urogynecol. J. 2010. Suppl. 2. P. S447–S451. DOI: 10.1007/s00192-010-1274-2

[45] Dwyer ME, Vandersteen DR, Hollatz P, et al. Sacral neuromodulation for the dysfunctional elimination syndrome: a 10-year single-center experience with 105 consecutive children. Urology. 2014;84:911–918. DOI: 10.1016/j.urology.2014.03.059

[46] Dwyer M.E., Vandersteen D.R., Hollatz P., et al. Sacral neuromodulation for the dysfunctional elimination syndrome: a 10-year single-center experience with 105 consecutive children // Urology. 2014. Vol. 84. P. 911–918. DOI: 10.1016/j.urology.2014.03.059

[47] Fuchs ME, Lu PL, Vyrostek SJ, et al. Factors predicting complications after sacral neuromodulation in children. Urology. 2017;107:214–217. DOI: 10.1016/j.urology.2017.05.014

[48] Fuchs M.E., Lu P.L., Vyrostek S.J., et al. Factors predicting complications after sacral neuromodulation in children // Urology. 2017. Vol. 107. P. 214–217. DOI: 10.1016/j.urology.2017.05.014

[49] Rensing AJ, Szymanski KM, Dunn S, et al. Pediatric sacral nerve stimulator explanation due to complications or cure: a survival analysis. J Pediatr Urol. 2019;15(1):e1–e6. DOI: 10.1016/j.jpurol.2018.10.010

[50] Rensing A.J., Szymanski K.M., Dunn S., et al. Pediatric sacral nerve stimulator explanation due to complications or cure: a survival analysis // J. Pediatr. Urol. 2019. Vol. 15. No. 1. P. e1–e6. DOI: 10.1016/j.jpurol.2018.10.010

[51] Pellegrino C, Bershadskii A, Lena F, et al. Sacral neuromodulation in pediatric population: what we learned after 65 implants. Continence. 2022;2:1–2. DOI: 10.1016/j.cont.2022.100438

[52] Pellegrino C., Bershadskii A., Lena F., et al. Sacral neuromodulation in pediatric population: what we learned after 65 implants // Continence. 2022. Vol. 2. Suppl. 2. P. 1–2. DOI: 10.1016/j.cont.2022.100438

[53] Guys JM, Haddad M, Planche D, et al. Sacral neuromodulation for neurogenic bladder dysfunction in children. J Urol. 2004;172:1673–1676. DOI: 10.1097/01.ju.0000138527.98969.b0

[54] Guys J.M. Haddad M., Planche D., et al. Sacral neuromodulation for neurogenic bladder dysfunction in children // J. Urol. 2004. Vol. 172. No. 4. Pt. 2. P. 1673–1676. DOI: 10.1097/01.ju.0000138527.98969.b0

[55] Haddad M, Besson R, Aubert D, et al. Sacral neuromodulation in children with urinary and fecal incontinence: a multicenter, open label, randomized, crossover study. J Urol. 2010:184:696–701. DOI: 10.1016/j.juro.2010.03.054

[56] Haddad M., Besson R., Aubert D., et al. Sacral neuromodulation in children with urinary and fecal incontinence: a multicenter, open label, randomized, crossover study // J. Urol. 2010. Vol. 184. P. 696–701. DOI: 10.1016/j.juro.2010.03.054

[57] Lu PL, Koppen IJ, Yacob D, et al. The prognostic value of manometry testing in children with constipation treated with sacral nerve stimulation. J Pediatr Gastroenterol Nutr. 2016;63(Suppl 2):S97–S8.

[58] Lu P.L., Koppen I.J., Yacob D., et al. The prognostic value of manometry testing in children with constipation treated with sacral nerve stimulation // J. Pediatr. Gastroenterol. Nutr. 2016. Vol. 63. Suppl. 2. P. 97–98.

[59] Schober MS, Sulkowski JP, Lu PL, et al. Sacral nerve stimulation for pediatric lower urinary tract dysfunction: development of a standardized pathway with objective urodynamic outcomes. J Urol. 2015;194(6):1721–1727. DOI: 10.1016/j.juro.2015.06.090

[60] Schober M.S., Sulkowski J.P., Lu P.L., et al. Sacral nerve stimulation for pediatric lower urinary tract dysfunction: development of a standardized pathway with objective urodynamic outcomes // J. Urol. 2015. Vol. 194. No. 6. P. 1721–1727. DOI: 10.1016/j.juro.2015.06.090

[61] Groen LA, Hoebeke P, Loret N, et al. Sacral neuromodulation with an implantable pulse generator in children with lower urinary tract symptoms: 15-year experience. J Urol. 2012;188:1313–1317. DOI: 10.1016/j.juro.2012.06.039

[62] Groen L.A., Hoebeke P., Loret N., et al. Sacral neuromodulation with an implantable pulse generator in children with lower urinary tract symptoms: 15-year experience // J. Urol. 2012. Vol. 188. P. 1313–1317. DOI: 10.1016/j.juro.2012.06.039

[63] Mosiello G, Safder S, Marshall D. Neurogenic bowel dysfunction in children and adolescents. J Clin Med. 2021;10(8):1669. DOI: 10.3390/jcm10081669

[64] Mosiello G., Safder S., Marshall D. Neurogenic bowel dysfunction in children and adolescents // J. Clin. Med. 2021. Vol. 10. No. 8. P. 1669. DOI: 10.3390/jcm10081669

[65] Hiller SC, Schober MS. Pediatric sacral neuromodulation for voiding dysfunction. In: Adult and Pediatric Neuromodulation. Ed. by J. Gilleran, S. Alpert. 2018:233–236. DOI: 10.1007/978-3-319-73266-4_17

[66] Hiller S.C., Schober M.S. Pediatric sacral neuromodulation for voiding dysfunction in adult and pediatric neuromodulation // Adult and Pediatric Neuromodulation / Ed. by J. Gilleran, S. Alpert. 2018. P. 233–236. DOI: 10.1007/978-3-319-73266-4_17

[67] Mason MD, Stephany HA, Casella DP, et al. Prospective evaluation of sacral neuromodulation in children: outcomes and urodynamic predictors of success. J Urol. 2016;195:1239–1244. DOI: 10.1016/j.juro.2015.11.034

[68] Mason M.D., Stephany H.A., Casella D.P., et al. Prospective evaluation of sacral neuromodulation in children: outcomes and urodynamic predictors of success // J. Urol. 2016. Vol. 195. P. 1239–1244. DOI: 10.1016/j.juro.2015.11.034

[69] Chen G, Liao L, Deng H. The effect of sacral neuromodulation in ambulatory spina bifida patients with neurogenic bladder and bowel dysfunction. Urology. 2021;153:345–350. DOI: 10.1016/j.urology.2020.11.075

[70] Chen G., Liao L., Deng H. The effect of sacral neuromodulation in ambulatory spina bifida patients with neurogenic bladder and bowel dysfunction // Urology. 2021. Vol. 153. P. 345-350. DOI: 10.1016/j.urology.2020.11.075

[71] Van der Jagt PKN, Dik P, Froeling M, et al. Architectural configuration and microstructural properties of the sacral plexus: a diffusion tensor MRI and fiber tractography study. NeuroImage. 2012;62(3):1792–1799. DOI: 10.1016/j.neuroimage.2012.06

[72] Van der Jagt P.K.N., Dik P., Froeling M., et al. Architectural configuration and microstructural properties of the sacral plexus: a diffusion tensor MRI and fiber tractography study // NeuroImage. 2012. Vol. 62. No. 3. P. 1792–1799. DOI: 10.1016/j.neuroimage.2012.06

[73] Sharifiaghdas F. Sacral neuromodulation in congenital lumbo-sacral and traumatic spinal cord defects with neurogenic lower urinary tract symptoms: a single-center experience in children and adolescents. World Journal of Urology. 2019;37(12):2775–2783. DOI: 10.1007/s00345-019-02721-x

[74] Sharifiaghdas F. Sacral neuromodulation in congenital lumbo-sacral and traumatic spinal cord defects with neurogenic lower urinary tract symptoms: a single-center experience in children and adolescents // World Journal of Urology. 2019. Vol. 37. No. 12. P. 2775–2783. DOI: 10.1007/s00345-019-02721-x

[75] Sievert KD, Amend B, Gakis G, et al. Early sacral neuromodulation prevents urinary incontinence after complete spinal cord injury. Ann Neurol. 2010;67:74–84. DOI: 10.1002/ana.21814

[76] Sievert K.D., Amend B., Gakis G., et al. Early sacral neuromodulation prevents urinary incontinence after complete spinal cord injury // Ann. Neurol. 2010. Vol. 67. P. 74–84. DOI: 10.1002/ana.21814

[77] Chen G, Liao L, Dong Q, et al. The inhibitory effects of pudendal nerve stimulation on bladder overactivity in spinal cord injury dogs: is early stimulation necessary? Neuromodulation. 2012;15:232–237. DOI: 10.1111/j.1525-1403.2012.00434.x

[78] Chen G., Liao L., Dong Q., et al. The inhibitory effects of pudendal nerve stimulation on bladder overactivity in spinal cord injury dogs: is early stimulation necessary? // Neuromodulation. 2012. Vol. 15. P. 232–237. DOI: 10.1111/j.1525-1403.2012.00434.x

[79] Lombardi G, Musco S, Celso M, et al. Intravesical electrostimulation versus sacral neuromodulation for incomplete spinal cord patients suffering from neurogenic non-obstructive urinary retention. Spinal Cord. 2013;51:571–578. DOI: 10.1038/sc.2013.37

[80] Lombardi G., Musco S., Celso M., et al. Intravesical electrostimulation versus sacral neuromodulation for incomplete spinal cord patients suffering from neurogenic non-obstructive urinary retention // Spinal Cord. 2013. Vol. 51. P. 571–578. DOI: 10.1038/sc.2013.37

[81] Hu M, Lai S, Zhang Y, et al. Sacral neuromodulation for lower urinary tract dysfunction in spinal cord injury: a systematic review and meta-analysis. Urol Inter. 2019;103(3):337–343. DOI: 10.1159/000501529

[82] Hu M., Lai S., Zhang Y., et al. Sacral neuromodulation for lower urinary tract dysfunction in spinal cord injury: a systematic review and meta-analysis // Urol. Inter. 2019. Vol. 103. No. 3. P. 337–343. DOI: 10.1159/000501529

[83] Sager C, Barroso UJr, Murillo J, et al. Management of neurogenic bladder dysfunction in children update and recommendations on medical treatment. Int Braz J Urol. 2022;48(1):31–51. DOI: 10.1590/S1677-5538.IBJU.2020.098

[84] Sager C., Barroso U.Jr., Murillo J., et al. Management of neurogenic bladder dysfunction in children update and recommendations on medical treatment // Int. Braz. J. Urol. 2022. Vol. 48. No. 1. P. 31–51. DOI: 10.1590/S1677-5538.IBJU.2020.098

[85] Humphreys MR, Vandersteen DR, Slezak JM, et al. Preliminary results of sacral neuromodulation in 23 children. J Urol. 2006;176(5):2227–2231. DOI: 10.1016/j.juro.2006.07.013

[86] Humphreys M.R., Vandersteen D.R., Slezak JM., et al. Preliminary results of sacral neuromodulation in 23 children // J. Urol. 2006. Vol. 176. No. 5. P. 2227–2231. DOI: 10.1016/j.juro.2006.07.013

[87] Routh JC, Cheng EY, Austin JC, et al. Design and methodological considerations of the centers for disease control and prevention urologic and renal protocol for the newborn and young child with spina bifida. J Urol. 2016;196(6):1728–1734. DOI: 10.1016/j.juro.2016.07.081

[88] Routh J.C., Cheng E.Y., Austin J.C., et al. Design and methodological considerations of the centers for disease control and prevention urologic and renal protocol for the newborn andyoung child with spina bifida // J. Urol. 2016. Vol. 196. No. 6. P. 1728–1734. DOI: 10.1016/j.juro.2016.07.081

[89] Van der Wilt AA, van Wunnik BPW, Sturkenboom R, et al. Sacral neuromodulation in children and adolescents with chronic constipation refractory to conservative treatment. International Journal of Colorectal Disease. 2016;31(8):1459–1466. DOI: 10.1007/s00384-016-2604-8

[90] Van der Wilt A.A., van Wunnik B.P.W., Sturkenboom R., et al. Sacral neuromodulation in children and adolescents with chronic constipation refractory to conservative treatment // International Journal of Colorectal Disease. 2016. Vol. 31. No. 8. P. 1459–1466. DOI: 10.1007/s00384-016-2604-8

[91] Lu PL, Koppen IJN, Orsagh-Yentis DK. Sacral nerve stimulation for constipation and fecal incontinence in children: long-term outcomes, patient benefit, and parent satisfaction. Neurogastroenterol Motil. 2017;30(2). DOI: 10.1111/nmo.13184

[92] Lu P.L., Koppen I.J.N., Orsagh-Yentis D.K. Sacral nerve stimulation for constipation and fecal incontinence in children: Long-term outcomes, patient benefit, and parent satisfaction // Neurogastroenterol. Motil. 2017. Vol. 30. No. 2. DOI: 10.1111/nmo.13184

[93] Koppen IJ, von Gontard A, Chase J, et al. Management of functional nonretentive fecal incontinence in children: recommendations from the International Children’s Continence Society. J Pediatr Urol. 2016;12(1):56–64. DOI: 10.1016/j.jpurol.2015.09.008

[94] Koppen I.J., von Gontard A., Chase J., et al. Management of functional nonretentive fecal incontinence in children: recommendations from the International Children’s Continence Society // J. Pediatr. Urol. 2016. Vol. 12. No. 1. P. 56–64. DOI: 10.1016/j.jpurol.2015.09.008

[95] Sulkowski JP, Nacion KM, Deans KJ, et al. Sacral nerve stimulation: a promising therapy for fecal and urinary incontinence and constipation in children. J Pediatr Surg. 2015;50(10):1644–1647. DOI: 10.1016/j.jpedsurg.2015.03.0

[96] Sulkowski J.P., Nacion K.M., Deans K.J., et al. Sacral nerve stimulation: a promising therapy for fecal and urinary incontinence and constipation in children // J. Pediatr. Surg. 2015. Vol. 50. No. 10. P. 1644–1647. DOI: 10.1016/j.jpedsurg.2015.03.0

[97] Ramage L, Malakounides G, Iacona R. Current state of neuromodulation for constipation and fecal incontinence in children: a systematic review. European Journal of Pediatric Surgery. 2019;29(6):495–503. DOI: 10.1055/s-0038-1677485

[98] Ramage L., Malakounides G., Iacona R. Current state of neuromodulation for constipation and fecal incontinence in children: a systematic review // Eur. J. Pediatr. Surg. 2019 Vol. 29. No. 6. P. 495–503. DOI: 10.1055/s-0038-1677485

[99] Clark C, Ngo T, Comiter CV, et al. Sacral nerve stimulator revision due to somatic growth. J Urol. 2011;186:1576–1580. DOI: 10.1016/j.juro.2011.03.098

[100] Clark C., Ngo T., Comiter C.V., et al. Sacral nerve stimulator revision due to somatic growth // J. Urol. 2011. Vol. 186. P. 1576–1580. DOI: 10.1016/j.juro.2011.03.098

[101] Boswell TC, Hollatz P, Hutcheson JC, et al. Device outcomes in pediatric sacral neuromodulation: a single center series of 187 patients. J Pediatr Urol. 2021;17(72):e1–e7. DOI: 10.1016/j.jpurol.2020.10.010

[102] Boswell T.C., Hollatz P., Hutcheson J.C., et al. Device outcomes in pediatric sacral neuromodulation: a single center series of 187 patients // J. Pediatr. Urol. 2021. Vol. 17. No. 72. P. e1–e7. DOI: 10.1016/j.jpurol.2020.10.010

[103] Siegel S, Kreder K, Takacs E, et al. Prospective randomized feasibility study assessing the effect of cyclic sacral neuromodulation on urinary urge incontinence in women. Female Pelvic Med Reconstr Surg. 2018;24(4):267–271. DOI: 10.1097/SPV.0000000000000457

[104] Siegel S., Kreder K., Takacs E., et al. Prospective randomized feasibility study assessing the effect of cyclic sacral neuromodulation on urinary urge incontinence in women // Female Pelvic Med. Reconstr. Surg. 2018. Vol. 24. No. 4. P. 267–271. DOI: 10.1097/SPV.0000000000000457

[105] Widmann B, Galata C, Warschkow R, et al. Success and complication rates after sacral neuromodulation for fecal incontinence and constipation: a single-center follow-up study. J Neurogastroenterol Motil. 2019;25(1):159–170. DOI: 10.5056/jnm17106

[106] Widmann B., Galata C., Warschkow R., et al. Success and complication rates after sacral neuromodulation for fecal incontinence and constipation: a single-center follow-up study // J. Neurogastroenterol. Motil. 2019. Vol. 25. No. 1. P. 159–170. DOI: 10.5056/jnm17106

[107] Stephany HA, Juliano TM, Clayton DB, et al. Prospective evaluation of sacral nerve modulation in children with validated questionnaires. J Urol. 2013;190(4):1516–1522. DOI: 10.1016/j.juro.2013.01.099

[108] Stephany H.A., Juliano T.M., Clayton D.B., et al. Prospective evaluation of sacral nerve modulation in children with validated questionnaires // J. Urol. 2013. Vol. 190. No. 4. P. 1516–1522. DOI: 10.1016/j.juro.2013.01.099

[109] Wright AJ, Haddad M. Electroneurostimulation for the management of bladder bowel dysfunction in childhood. Eur J Paediatr Neurol. 2017;21(1):67–74. DOI: 10.1016/j.ejpn.2016.05.012

[110] Wright A.J., Haddad M. Electroneurostimulation for the management of bladder bowel dysfunction in childhood // Eur. J. Paediatr. Neurol. 2017. Vol. 21. No. 1. P. 67–74. DOI: 10.1016/j.ejpn.2016.05.012

[111] Sayed D, Chakravarthy K, Amirdelfan K, et al. ASPN MRI Compatibility Working Group. A comprehensive practice guideline for magnetic resonance imaging compatibility in implanted neuromodulation devices. Neuromodulation. 2020;23(7):893–911. DOI: 10.1111/ner.13233

[112] Sayed D., Chakravarthy K., Amirdelfan K., et al; ASPN MRI Compatibility Working Group, Deer T. A comprehensive practice guideline for magnetic resonance imaging compatibility in implanted neuromodulation devices // Neuromodulation. 2020. Vol. 23. No. 7. P. 893–911. DOI: 10.1111/ner.13233

[113] Matzel KE, Chartier-Kastler E, Knowles CH, et al. Sacral neuromodulation: standardized electrode placement technique. Neuromodulation. 2017;20(8):816–824. DOI: 10.1111/ner.12695

[114] Matzel K.E., Chartier-Kastler E., Knowles C.H., et al. Sacral neuromodulation: standardized electrode placement technique // Neuromodulation. 2017. Vol. 20. No. 8. P. 816–824. DOI: 10.1111/ner.12695

RIGHTS & PERMISSIONS

Khodorovskaya AM, Novikov VA, Zvosil AV, Umnov VV, Zharkov DS, Umnov DV, Vissarionov SV